This is a US news story, published by FIKKU.COM.
For more US news, you can click here:
more US newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from FIKKU.COM, you can click here:
more news from FIKKU.COMOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
pharmaceutical world. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pharmacies news, US pharmacies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pharmaceutical industryFIKKU.COM
•
52% Informative
Ozempic and other GLP-1 agonists have no real precedents, and that’s breaking the rules of the game.
Hundreds of US pharmacies have been manufacturing and marketing this type of medication without paying a dollar to the patent owners.
Legal loophole allows pharmacies to manufacture versions of patented medications under certain circumstances.
VR Score
36
Informative language
25
Neutral language
57
Article tone
informal
Language
English
Language complexity
64
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links